Echo Therapeutics is on the ropes
Orthofix CFO bails after 6 months amid deepening financial fix
Zoll, Philips win Defense Dept. contracts
FDA guides on custom devices
The FDA yesterday released its final recommendations for legal exemptions for customized medical devices that deviate from already-approved systems by being tailored to the special needs of up to 5 patients.
Examples of such devices might include implantable devices like artificial discs or surgical screws for very tall people or infants that are otherwise unavailable in the correct size.
Vital Therapies looks to tap the market for $46M more
Vital Therapies (NSDQ:VTL) registered a $46 million public stock offering for its technique for the regeneration of liver tissue.
Palmaz Scientific uncorks more funding
Palmaz Scientific recorded $1.3 million of a planned $4.2 million funding round for the prosthetic implant technology it’s developing in Dallas.
TAVI: Boston Scientific launches U.S. Lotus valve trial
T2 Biosystems jumps on FDA nod for sepsis tests
Abbott Vascular to shutter Texas plant, move 50 jobs to California
Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent
Ivantis today said it added a $25 million tranche to its now $71 million Series B round as the Irvine, Calif.-based company looks to bring its miniature glaucoma scaffold to the U.S. market.